# ARF5

## Overview
ARF5 (ADP ribosylation factor 5) is a gene that encodes a member of the ARF family of small GTP-binding proteins, which are integral to the regulation of vesicular trafficking and organelle structure within cells. The protein product, ADP ribosylation factor 5, functions primarily as a molecular switch, cycling between active and inactive states to facilitate various cellular processes, particularly within the Golgi apparatus. As a GTPase, ARF5 is involved in the secretory pathway and plays a critical role in maintaining Golgi integrity and regulating membrane traffic and cytoskeletal dynamics. Its interactions with other proteins, such as arfophilin and clathrin adaptor protein complexes, underscore its specificity and importance in cellular homeostasis. Additionally, ARF5 has been implicated in cancer biology, particularly in breast cancer, where its expression levels correlate with disease progression and immune cell infiltration in the tumor microenvironment (Li2022ADPRibosylation; Donaldson2011ARF; Yang2024Association).

## Structure


## Function
ARF5 (ADP ribosylation factor 5) is a member of the ARF family of GTP-binding proteins that play a crucial role in vesicular trafficking and organelle structure. In healthy human cells, ARF5 is primarily active in the Golgi apparatus, where it influences processes such as protein sorting and lipid metabolism (Li2022ADPRibosylation). ARF5 functions as a molecular switch, cycling between active (GTP-bound) and inactive (GDP-bound) states, which is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) (Li2022ADPRibosylation).

ARF5 is involved in the secretory pathway, particularly in the ER-Golgi intermediate compartment (ERGIC), where it associates independently of the guanine nucleotide exchange factor GBF1. This suggests that ARF5 has specific binding sites and roles distinct from other ARFs like ARF1 (Chun2008Characterization). The protein is also implicated in the regulation of membrane traffic and cytoskeletal dynamics, contributing to the maintenance of Golgi integrity and the regulation of retrograde traffic from vesicular-tubular clusters (VTCs) back to the ER (VolpicelliDaley2005Isoformselective). These functions highlight ARF5's importance in maintaining cellular homeostasis and efficient intracellular transport.

## Clinical Significance
ARF5 (ADP ribosylation factor 5) has been implicated in breast cancer, where its expression is significantly upregulated compared to normal tissues. High mRNA expression levels of ARF5 are associated with advanced breast cancer stages and subtypes, and it has been linked to decreased distant metastasis-free survival (DMFS) in patients. This suggests that ARF5 could serve as a prognostic marker in breast cancer (Yang2024Association).

ARF5 also appears to play a role in modulating the tumor immune microenvironment. Its expression negatively correlates with the infiltration of various immune cells, including B cells, CD8+ T cells, macrophages, neutrophils, and dendritic cells in breast cancer patients. This indicates that ARF5 may influence immune cell dynamics within the tumor microenvironment, potentially affecting cancer progression and patient prognosis (Yang2024Association).

While ARF5's role in other cancers is not specifically detailed, its involvement in cellular processes such as vesicular trafficking and organelle structure suggests that dysregulation could contribute to tumor growth and metastasis in other contexts as well (Donaldson2011ARF; Casalou2020The). Further research is needed to fully understand its clinical significance across different cancer types.

## Interactions
ARF5, a member of the ADP-ribosylation factor family, participates in various protein interactions crucial for its role in cellular processes. It interacts specifically with arfophilin, a novel protein that binds exclusively to the GTP-bound form of ARF5. This interaction is mediated by the N-terminal sequence of ARF5 and the C-terminal region of arfophilin, which contains putative coiled-coil structures (Shin1999Identification). 

ARF5 also interacts with clathrin adaptor protein complexes, particularly AP-1, through direct binding to the β1-adaptin subunit in the presence of GTPγS. However, it does not interact with the β3-and δ-adaptin subunits of AP-3, indicating a selective interaction pattern (Austin2002SiteSpecific). 

In addition, ARF5 is involved in interactions with GGA proteins at the trans-Golgi network. These interactions are facilitated by the GGAH domain of GGA proteins, which binds to the GTP-bound form of ARF5, playing a role in recruiting GGA proteins to membranes (TAKATSU2002GGA).

ARF5 has also been identified as an RNA-binding protein, interacting with specific RNA subdomains, such as SL3a, SL3abc, and SL123, albeit with lower affinity compared to other proteins like Rab1b (FernandezChamorro2019Rab1b).


## References


[1. (Chun2008Characterization) Justin Chun, Zoya Shapovalova, Selma Y. Dejgaard, John F. Presley, and Paul Melançon. Characterization of class i and ii adp-ribosylation factors (arfs) in live cells: gdp-bound class ii arfs associate with the er-golgi intermediate compartment independently of gbf1. Molecular Biology of the Cell, 19(8):3488–3500, August 2008. URL: http://dx.doi.org/10.1091/mbc.e08-04-0373, doi:10.1091/mbc.e08-04-0373. This article has 1 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e08-04-0373)

[2. (TAKATSU2002GGA) Hiroyuki TAKATSU, Kaori YOSHINO, Kyoko TODA, and Kazuhisa NAKAYAMA. Gga proteins associate with golgi membranes through interaction between their ggah domains and adp-ribosylation factors. Biochemical Journal, 365(2):369–378, July 2002. URL: http://dx.doi.org/10.1042/bj20020428, doi:10.1042/bj20020428. This article has 101 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20020428)

[3. (FernandezChamorro2019Rab1b) Javier Fernandez-Chamorro, Rosario Francisco-Velilla, Jorge Ramajo, and Encarnación Martinez-Salas. Rab1b and arf5 are novel rna-binding proteins involved in fmdv ires–driven rna localization. Life Science Alliance, 2(1):e201800131, January 2019. URL: http://dx.doi.org/10.26508/lsa.201800131, doi:10.26508/lsa.201800131. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.26508/lsa.201800131)

[4. (Austin2002SiteSpecific) Carol Austin, Markus Boehm, and Sharon A. Tooze. Site-specific cross-linking reveals a differential direct interaction of class 1, 2, and 3 adp-ribosylation factors with adaptor protein complexes 1 and 3. Biochemistry, 41(14):4669–4677, March 2002. URL: http://dx.doi.org/10.1021/bi016064j, doi:10.1021/bi016064j. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi016064j)

[5. (Donaldson2011ARF) Julie G. Donaldson and Catherine L. Jackson. Arf family g proteins and their regulators: roles in membrane transport, development and disease. Nature Reviews Molecular Cell Biology, 12(6):362–375, May 2011. URL: http://dx.doi.org/10.1038/nrm3117, doi:10.1038/nrm3117. This article has 762 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm3117)

[6. (Casalou2020The) Cristina Casalou, Andreia Ferreira, and Duarte C. Barral. The role of arf family proteins and their regulators and effectors in cancer progression: a therapeutic perspective. Frontiers in Cell and Developmental Biology, April 2020. URL: http://dx.doi.org/10.3389/fcell.2020.00217, doi:10.3389/fcell.2020.00217. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.00217)

[7. (Yang2024Association) Lixian Yang, Shiyu Zhang, Lei Zheng, Fanting Kong, Pengpeng Pu, Xiaowei Li, and Lining Jia. Association of adp‑ribosylation factor family genes with prognosis and immune infiltration of breast cancer. Oncology Letters, April 2024. URL: http://dx.doi.org/10.3892/ol.2024.14413, doi:10.3892/ol.2024.14413. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2024.14413)

[8. (Li2022ADPRibosylation) Tiantian Li and Yusong Guo. Adp-ribosylation factor family of small gtp-binding proteins: their membrane recruitment, activation, crosstalk and functions. Frontiers in Cell and Developmental Biology, February 2022. URL: http://dx.doi.org/10.3389/fcell.2022.813353, doi:10.3389/fcell.2022.813353. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.813353)

[9. (Shin1999Identification) Ok-Ho Shin, Annette H. Ross, Irene Mihai, and John H. Exton. Identification of arfophilin, a target protein for gtp-bound class ii adp-ribosylation factors. Journal of Biological Chemistry, 274(51):36609–36615, December 1999. URL: http://dx.doi.org/10.1074/jbc.274.51.36609, doi:10.1074/jbc.274.51.36609. This article has 57 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.274.51.36609)

[10. (VolpicelliDaley2005Isoformselective) Laura A. Volpicelli-Daley, Yawei Li, Chun-Jiang Zhang, and Richard A. Kahn. Isoform-selective effects of the depletion of adp-ribosylation factors 1–5 on membrane traffic. Molecular Biology of the Cell, 16(10):4495–4508, October 2005. URL: http://dx.doi.org/10.1091/mbc.e04-12-1042, doi:10.1091/mbc.e04-12-1042. This article has 205 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e04-12-1042)